80 FR 22525 - Office of Child Support Enforcement; Notice of Consultation

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Administration for Children and Families

Federal Register Volume 80, Issue 77 (April 22, 2015)

Page Range		22525-22526
FR Document		2015-09351

The Department of Health and Human Services, Administration for Children and Families (ACF), Office of Child Support Enforcement (OCSE) will host a Tribal Consultation to consult on the implementation of Section 302 of Public Law 113-183, the Preventing Sex Trafficking and Strengthening Families Act of 2014 (Act).

Federal Register, Volume 80 Issue 77 (Wednesday, April 22, 2015)

[Federal Register Volume 80, Number 77 (Wednesday, April 22, 2015)]
[Notices]
[Pages 22525-22526]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-09351]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Administration for Children and Families


Office of Child Support Enforcement; Notice of Consultation

AGENCY: Administration for Children and Families, Department of Health 
and Human Services.

ACTION: Notice of Tribal Consultation.

-----------------------------------------------------------------------

SUMMARY: The Department of Health and Human Services, Administration 
for Children and Families (ACF), Office of Child Support Enforcement 
(OCSE) will host a Tribal Consultation to consult on the implementation 
of Section 302 of Public Law 113-183, the Preventing Sex Trafficking 
and Strengthening Families Act of 2014 (Act).

DATES: May 20, 2015

ADDRESSES: 901 D Street SW., Room 4 E 8, the Aerospace Building, 
Washington, DC 20447.

FOR FURTHER INFORMATION CONTACT: Paige Hausburg, Tribal Coordinator, 
OCSE, at (202) 401-5635, by email at [email protected], or by 
mail at 370 L'Enfant Promenade SW., 4th Floor East, Washington, DC 
20447.

SUPPLEMENTARY INFORMATION: On September 29, 2014, the President signed 
Public Law 113-183, the Preventing Sex Trafficking and Strengthening 
Families Act of 2014 (Act). Section 302 of the Act, which authorizes 
direct access to the Federal Parent Locator Service (FPLS), is below.

Section 302. Child Support Enforcement Programs for Indian Tribes

    a. Tribal Access to the FPLS. The law amends section 453(c)(1) of 
the Act to add an agent or attorney of an ``Indian tribe or tribal 
organization [as defined in subsections (e) and (l) of section 4 of the 
Indian Self-Determination and Education Assistance Act (25 U.S.C. 
450b)]'' as an additional authorized person that the FPLS may provide 
information for the purpose of establishing parentage or establishing, 
setting the amount of, modifying, or enforcing child support 
obligations.
    b. Waiver Authority for Indian Tribes or Tribal Organizations 
Operating Child Support Enforcement Programs. The law amends section 
1115(b) of the Act to provide that an Indian tribe or tribal 
organization operating a IV-D program shall be considered a state for 
purposes of authority to conduct an experimental, pilot, or 
demonstration project. The Secretary may waive compliance with any 
requirements or regulations to the extent and for the period the 
Secretary finds necessary for an Indian tribe or tribal organization to 
carry out such project. Costs of the project that would not otherwise 
be included as expenditures of a program shall, to the extent and for 
the period prescribed by the Secretary, be regarded as expenditures 
under a tribal plan or plans approved under such section or for the 
administration of such tribal plan or plans as may be appropriate. A 
start-up program is not eligible for this program.
    On October 16, 2014, OCSE hosted a Tribal IV-D Directors call to 
discuss Section 302. During that call, OCSE described FPLS access to 
the National Directory of New Hires (NDNH), Federal Case Registry 
(FCR), External locates, Multistate Financial Institution Data Match 
(MSFIDM) and Insurance Match (IM).
    On January 14, 2015, OCSE sent an email message to the Tribal IV-D 
Director's listserv to inform directors that OCSE was conducting an 
analysis of tribal access to key FPLS functions including the NDNH, 
FCR, External locates, Department of Defense (DOD) Entitlements, and 
Employer Search, using the federal Child Support portal. OCSE can 
provide access to these functions via the internet without tribal cases 
being registered on the FCR or debtors being submitted for MSFIDM and 
IM.
    During consultation OCSE wants to discuss and gather information 
about the implications and responsibilities of FPLS access.

Discussion Topics

 What FPLS access means
 Requirements and design
 Discussion about the legislative requirements for fees
    [cir] Required by statute to charge a fee for FPLS data
    [cir] Standard fee methodology that is designed to distribute costs 
to all users
    [cir] Start-up fee to cover additional administrative and 
development costs
    [cir] How fees will be paid
 Security agreements
    [cir] Security posture, security controls, and how the FPLS data is 
protected
    [cir] Required physical security
    [cir] Required security agreements
 Training for access
    [cir] OCSE training
    [cir] Best method/frequency for training
 Phased access of FPLS
    [cir] Locates, FCR Query, DOD Entitlements, and Employer Search
    [cir] Tribal cases on the FCR
    [cir] MSFIDM and IM--to take advantage of these remedies cases must 
be on the debtor file
 Conversations with Tribal IV-D Directors
    [cir] Number and Frequency of meetings
 Project Plan
    [cir] Requirements/analysis/design by August 2015
    [cir] Development and testing by January 2016
    [cir] Implementation and Training January-February 2016
    Testimonies should be submitted no later than May 15, 2015, to: 
Vicki Turetsky, Commissioner, Office of Child Support Enforcement, 370 
L'Enfant Promenade SW., Washington, DC 20447.

[[Page 22526]]

    Testimonies may also be submitted to this email address: 
[email protected]. Registration to attend the consultation can 
be done using this link: http://events.constantcontact.com/register/event?llr=vt7m85dab&oeidk=a07eau2syfc09b2fe8f.
    Please register by May 18, 2015, so that OCSE can include everyone 
registered in the building access system to assure their entry. OCSE is 
located in a federal building and the security protocol requires 
government identification.
    OCSE understands that resources are limited and travel may not be 
possible for some tribal leaders. In order to engage as many tribal 
leaders as possible, individuals who are unable to travel to 
Washington, DC, can connect to the meeting via a conference call. The 
call-in number is 1-866-642-2926, participant passcode is 1436048. The 
URL for the webinar is: http://hhs.adobeconnect.com/drotribal/. To join 
by phone, please register using the link above.

    Dated: April 16, 2015.
Donna Bonar,
Deputy Commissioner, Office of Child Support Enforcement.
[FR Doc. 2015-09351 Filed 4-21-15; 8:45 am]
BILLING CODE 4184-41-P

22526 Federal Register / Vol. 80, No. 77 / Wednesday, April 22, 2015 / Notices

Testimonies may also be submitted to and improve the quality of protocols Trial Endpoints for the Approval of
this email address: Paige.Hausburg@ submitted to FDA to support anticancer Non-Small Cell Lung Cancer Drugs and
acf.hhs.gov. Registration to attend the effectiveness claims. This guidance Biologics’’ issued June 17, 2011 (76 FR
consultation can be done using this link: finalizes the draft guidance issued on 35450). Comments received from
http://events.constantcontact.com/ June 17, 2011. industry, professional societies, and
register/event?llr=vt7m85dab&oeidk DATES: Submit either electronic or consumer groups on the draft guidance
=a07eau2syfc09b2fe8f. written comments on Agency guidances have been taken into consideration by
Please register by May 18, 2015, so at any time. FDA in finalizing this guidance and
that OCSE can include everyone ADDRESSES: Submit written requests for some of the changes are summarized
registered in the building access system single copies of this guidance to the here. Sections II.A. and III. have been
to assure their entry. OCSE is located in Division of Drug Information, Center for clarified based on the comments
a federal building and the security Drug Evaluation and Research, Food received and FDA’s current thinking
protocol requires government and Drug Administration, 10001 New and practice regarding the magnitude of
identification. Hampshire Ave., Hillandale Building, treatment effect based on progression-
OCSE understands that resources are free survival. Appendices C and D have
4th Floor, Silver Spring, MD 20993–
limited and travel may not be possible also been clarified based on the
0002; or Office of Communication,
for some tribal leaders. In order to comments received and FDA’s view on
engage as many tribal leaders as Outreach, and Development, Center for
Biologics Evaluation and Research, primary and sensitivity analyses of
possible, individuals who are unable to progression-free survival. The language
travel to Washington, DC, can connect Food and Drug Administration, 10903
New Hampshire Ave., Bldg. 71, rm. in the guidance has been simplified to
to the meeting via a conference call. The be concise.
call-in number is 1–866–642–2926, 3128, Silver Spring, MD 20993–0002.
This guidance is being issued
participant passcode is 1436048. The Send one self-addressed adhesive label
consistent with FDA’s good guidance
URL for the webinar is: http:// to assist that office in processing your
practices regulation (21 CFR 10.115).
hhs.adobeconnect.com/drotribal/. To requests. See the SUPPLEMENTARY
The guidance represents the current
join by phone, please register using the INFORMATION section for electronic
thinking of FDA on clinical trial
link above. access to the guidance document.
Submit electronic comments on the endpoints for the approval of non-small
Dated: April 16, 2015. guidance to http://www.regulations.gov. cell lung cancer drugs and biologics. It
Donna Bonar, Submit written comments to the does not establish any rights for any
Deputy Commissioner, Office of Child Division of Dockets Management (HFA– person and is not binding on FDA or the
Support Enforcement. 305), Food and Drug Administration, public. You can use an alternative
[FR Doc. 2015–09351 Filed 4–21–15; 8:45 am] 5630 Fishers Lane, rm. 1061, Rockville, approach if it satisfies the requirements
BILLING CODE 4184–41–P MD 20852. of the applicable statutes and
regulations.
FOR FURTHER INFORMATION CONTACT:
Rajeshwari Sridhara, Center for Drug II. The Paperwork Reduction Act of
DEPARTMENT OF HEALTH AND Evaluation and Research, Food and 1995
HUMAN SERVICES Drug Administration, 10903 New This guidance refers to previously
Food and Drug Administration Hampshire Ave., Bldg. 21, rm. 3512, approved collections of information that
Silver Spring, MD 20993–0002, 301– are subject to review by the Office of
[Docket No. FDA–2011–D–0432] 796–1759; or Stephen Ripley, Center for Management and Budget (OMB) under
Biologics Evaluation and Research, the Paperwork Reduction Act of 1995
Clinical Trial Endpoints for the Food and Drug Administration, 10903
Approval of Non-Small Cell Lung (44 U.S.C. 3501–3520). The collections
New Hampshire Ave., Bldg. 71, rm. of information in 21 CFR parts 312, 314,
Cancer Drugs and Biologics; Guidance 7301, Silver Spring, MD 20993–0002,
for Industry; Availability and 601 have been approved under
240–402–7911. OMB control numbers 0910–0014,
AGENCY: Food and Drug Administration, SUPPLEMENTARY INFORMATION: 0910–0001, and 0910–0338,
HHS. respectively.
I. Background
ACTION: Notice.
FDA is announcing the availability of III. Comments
SUMMARY: The Food and Drug a guidance for industry entitled Interested persons may submit either
Administration (FDA or Agency) is ‘‘Clinical Trial Endpoints for the electronic comments regarding this
announcing the availability of a Approval of Non-Small Cell Lung document to http://www.regulations.gov
guidance for industry entitled ‘‘Clinical Cancer Drugs and Biologics.’’ FDA is or written comments to the Division of
Trial Endpoints for the Approval of developing guidance on oncology Dockets Management (see ADDRESSES).
Non-Small Cell Lung Cancer Drugs and endpoints through a process that It is only necessary to send one set of
Biologics.’’ This guidance provides includes public workshops of oncology comments. Identify comments with the
recommendations to applicants on experts and discussions before FDA’s docket number found in brackets in the
endpoints for cancer clinical trials Oncologic Drugs Advisory Committee. heading of this document. Received
submitted to FDA to support This guidance provides background comments may be seen in the Division
effectiveness claims in new drug information and general principles. The
asabaliauskas on DSK5VPTVN1PROD with NOTICES

of Dockets Management between 9 a.m.
applications, biologics license endpoints discussed in this guidance and 4 p.m., Monday through Friday, and
applications, or supplemental are for drugs to treat patients with will be posted to the docket at http://
applications for the treatment of non- existing non-small cell lung cancer. This www.regulations.gov.
small cell lung cancer. This guidance guidance does not address endpoints for
focuses on endpoints specifically for drugs to prevent or decrease the IV. Electronic Access
lung cancer trials to support drug incidence of cancer. Persons with access to the Internet
approval or labeling claims. This This guidance finalizes the draft may obtain the document at http://
guidance should speed the development guidance for industry entitled ‘‘Clinical www.fda.gov/Drugs/

VerDate Sep<11>2014 18:00 Apr 21, 2015 Jkt 235001 PO 00000 Frm 00054 Fmt 4703 Sfmt 4703 E:\FR\FM\22APN1.SGM 22APN1

Document Created: 2015-12-16 08:27:20
Document Modified: 2015-12-16 08:27:20

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Action		Notice of Tribal Consultation.
Dates		May 20, 2015
Contact		Paige Hausburg, Tribal Coordinator, OCSE, at (202) 401-5635, by email at [email protected], or by mail at 370 L'Enfant Promenade SW., 4th Floor East, Washington, DC 20447.
FR Citation		80 FR 22525

80 FR 22525 - Office of Child Support Enforcement; Notice of Consultation

DEPARTMENT OF HEALTH AND HUMAN SERVICESAdministration for Children and Families

Federal Register Volume 80, Issue 77 (April 22, 2015)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Administration for Children and Families